Belmac
This article was originally published in The Tan Sheet
Executive Summary
President and CEO Michael Harshbarger, whose term ran for five months, leaves the firm. In February, Belmac accepted the resignations of Chairman and CEO Jean-Francoise Rossignol, Chief Financial Officer Max Huguet and Senior VP Vittorio Ferraris. The Tampa-based company has not appointed a replacement for Harshbarger, but said that the post is being discussed with a candidate with a "strong" pharmaceutical background.